12:00 AM
 | 
Nov 12, 2001
 |  BioCentury  |  Politics, Policy & Law

Looking to pay for MS drugs

As Britain's National Institute for Clinical Excellence reiterates its negative recommendation on the beta interferon and glatiramer to treat multiple sclerosis, the Department of Health in England and Wales is looking for some scheme to fund treatment with the drugs.
NICE has published its draft Final Appraisal Determination, and although it does not yet...

Read the full 240 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >